Anaphylaxis: A 2023 practice parameter update.
Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Abrams EM, Bernstein JA, Chu DK, Horner CC, Rank MA, Stukus DR; Collaborators; Burrows AG, Cruickshank H; Workgroup Contributors; Golden DBK, Wang J, Akin C, Campbell RL, Ellis AK, Greenhawt M, Lang DM, Ledford DK, Lieberman J, Oppenheimer J, Shaker MS, Wallace DV, Waserman S; Joint Task Force on Practice Parameters Reviewers; Abrams EM, Bernstein JA, Chu DK, Ellis AK, Golden DBK, Greenhawt M, Horner CC, Ledford DK, Lieberman J, Rank MA, Shaker MS, Stukus DR, Wang J.
Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-176. doi: 10.1016/j.anai.2023.09.015. Epub 2023 Dec 18.
Health Benefits of Lactic Acid Bacteria (LAB) Fermentates.
Mathur H, Beresford TP, Cotter PD.
Nutrients. 2020 Jun 4;12(6):1679. doi: 10.3390/nu12061679.
Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors.
Lip GY, Ferner RE.
J Hum Hypertens. 1995 Sep;9(9):711-5.
Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions.
Carlson GS, Wong PH, White KM, Quinn JM.
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1430-1432. doi: 10.1016/j.jaip.2017.05.009. Epub 2017 Jul 8.
Ramipril-associated hepatotoxicity.
Yeung E, Wong FS, Wanless IR, Shiota K, Guindi M, Joshi S, Gardiner G.
Arch Pathol Lab Med. 2003 Nov;127(11):1493-7. doi: 10.5858/2003-127-1493-RH.
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
Sonsalla PK, Coleman C, Wong LY, Harris SL, Richardson JR, Gadad BS, Li W, German DC.
Exp Neurol. 2013 Dec;250:376-83. doi: 10.1016/j.expneurol.2013.10.014. Epub 2013 Oct 30.
Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver.
Reza HM, Tabassum N, Sagor MA, Chowdhury MR, Rahman M, Jain P, Alam MA.
Toxicol Mech Methods. 2016;26(1):46-53. doi: 10.3109/15376516.2015.1124956. Epub 2016 Feb 10.
Angiotensin-Converting Enzyme Inhibitor-Drug Induced Liver Injury: Clinical Features and Diagnostic Features - A Systematic Review of Current Reported Cases.
Suenghataiphorn T, Tribuddharat N, Danpanichkul P, Kulthamrongsri N.
Korean J Gastroenterol. 2025 Apr 25;85(2):194-200. doi: 10.4166/kjg.2025.008.
Les enjeux de la surcharge hydro-sodée.
Vrtovsnik F, Fartoux L.
Nephrol Ther. 2016 Dec;12(7S):S10-S11. doi: 10.1016/S1769-7255(17)30020-2.
Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease.
Park HY, Lee GS, Go J, Ryu YK, Lee CH, Moon JH, Kim KS.
Eur J Pharmacol. 2024 Jun 15;973:176573. doi: 10.1016/j.ejphar.2024.176573. Epub 2024 Apr 19.
